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ABSTRACTSResults: 16 of 183 (8.7%) patients had increased LOS. Mean age was 74 y
(SD+-15y). Total LOS for the cohort was 366d (mean LOS 22d, SD+-20d) and
corrected LOS was 245d (mean 15.4d, SD+-18.8d). Surgical Sepsis
accounted for 143d, social service delays for 83d and intervention services
delays for 18d. There was no signiﬁcant difference for age between factors.
Overall estimated annual extra bed cost was£661500.
Conclusion: Incidence of surgical sepsis and the efﬁciency of intervention
services and social services should be targeted to reduce prolonged sur-
gical LOS.
0201: OUTPATIENT FLUID AND ELECTROLYTE MANAGEMENT FOR PA-
TIENTS WITH HIGH OUTPUT STOMAS AND ENTEROCUTANEOUS
FISTULAE
N.D. Appleton, A. Corris, C. Edwards, A. Kenyon, C.J. Walsh. Wirral
University Teaching Hospital NHS Foundation Trust, Wirral, UK.
Aim: Fluid and electrolyte management for patients with high output
stomas/enterocutaneous ﬁstulae is challenging. Historically, their care
required repeated admissions to avoid ongoing complications eg, acute
renal failure. We report our experience of outpatient management of such
patients led by a nutrition support team.
Method: A retrospective analysis of a prospectively maintained data-
base was performed. All patients met their nutrition needs enterally.
Patients attend a ward based clinic with facilities for monitoring
(weight, ﬂuid balance, diet, PICC line care, bloods, urinary sodium and
medication review) and IV hydration and/or magnesium/potassium
supplementation. Individual cases are discussed at a weekly nutrition
support meeting.
Results: Between September 2009 - September 2012, 83 patients attended
(male:female 43:40, median age 66, range 18-92). 73 had high output
stomas, 11 had enterocutaneous ﬁstulas. Total clinic days attended was
1239 (median 9 range 1-109 days). On 224 visits, IV ﬂuids were adminis-
tered, of which 95 were given IV magnesium and three, IV potassium.
Eleven required admission (admission rate of 1%). Other outcomes were
either optimisation for surgery, discharge without surgery or long term
monitoring without inpatient stay.
Conclusion: Patients with complex ﬂuid balance and electrolyte needs can
be managed successfully in the outpatient setting.
0236: IS LAPAROSCOPIC SURGERY FOR RIGHT HEMICOLECTOMY COST-
EFFECTIVE?
Sarah Daniels, Arin Saha, Victoria Proctor, Khalid Habib. Doncaster Royal
Inﬁrmary, Doncaster, South Yorkshire, UK.
Aim: To compare oncological outcomes and cost of laparoscopic and open
surgery for right hemicolectomy.
Methods: Patients who had a right hemicolectomy from January to
November 2011 were identiﬁed from a prospectively maintained database
of operations. Oncological outcomes were recorded and costs of surgery
were calculated by costing each item of equipment used for each case.
Results: There were 44 patients (28 men (64%); median age 72.8 years
(range, 18.4-89.2)). Thirty-two patients (73%) had elective surgery. Thirty
patients (68%) had a laparoscopic operation (3 converted). Of the 17 open
cases, 8 (47%) were acute cases as compared to 4 emergency cases out of 27
laparoscopic cases (15%, P¼0.019). Primary pathology was cancer in 37 pa-
tients (84%). There were no differences between laparoscopic and open
surgery in surgical time (181 minutes vs. 134 minutes [open], P¼0.593),
resected nodes (18 vs. 16, P¼0.968), distance to nearest longitudinal margin
(65 cms vs. 75 cms, P¼0.078) or inpatient stay (7 vs. 8, P¼0.681). Laparo-
scopic surgery was signiﬁcantly more expensive (£1014 vs. £439, P¼0.032).
Conclusions: Laparoscopic surgery for right hemicolectomy is associated
with equivalent oncological adequacy but is considerably more expensive
than open surgery. This may be important in healthcare planning with
future ﬁnancial constraints.
0238: “ASSESSMENT OF ACCURACY IN PREDICTING SITE OF COLO-
RECTAL CANCER AT ENDOSCOPY”
James Davies, Sarah Mills. Wansbeck General Hospital, Ashington,
Northumberlan, UK.
Aim: Colorectal cancer is the third most common cancer in the UK with
endoscopy playing an important role in the bowel screening programme.
Site of cancer will determine type of surgery and any further investigation.This audit was undertaken to assess our accuracy in predicting site of
cancer.
Method: A central database was used to identify cases. Speciﬁc site of
cancer was compared against documented site at endoscopy, using a
standard of90% accuracy, as proposed by JAG (Joint Advisory Group on GI
Endoscopy).
Results: 357 cases were identiﬁed from 2011/12, and 315 included. 233
tumours (74%) were accurately sited. Most sited incorrectly were of little
signiﬁcance, however within the rectal cancer group (n¼108), 7 were
deemed recto-sigmoid and 8 sigmoid. Only 67% of rectal tumours had
distance from anal margin documented.
Conclusion: Accuracy was below standard which in part may be due to
poor documentation. There is confusion, particularly around rectal tu-
mours, but this group is of high importance as mistakes could delay
imaging (MRI) and treatment. This highlights a potential pothole and it
is vital that endoscopists have an understanding of anatomy and its
surgical relevance. We will address our ﬁndings at re-audit.0252: THE USE OF ORAL IRON SUPPLEMENTATION AT DISCHARGE
FOLLOWING COLORECTAL CANCER RESECTION - WE COULD DO BETTER
Debashis Dass, Thomas J. Edwards, Ian Eyre-Brooks, Louise E. Hunt,
Paul M. Mackey, Christopher J. Vickery, Catherine J. Walter. Musgrove
Park Hospital Foundation Trust, Taunton, Somerset, UK.
Aims: Iron-deﬁciency is common following colorectal cancer (CRC) resec-
tion. For those who require adjuvant chemotherapy, pre-existing anaemia
increases the risk of requiring blood transfusion. We aimed to assess current
provisions of post-operative oral iron supplementation (Fe++).
Methods: In 2011, we undertook a single-centre retrospective study of
patients undergoing potentially-curative CRC resections. Demographic,
haematological, histological and therapeutic data was retrieved. Follow-up
haematological data was obtained for a cohort of patients who re-attended
for adjuvant chemotherapy.
Results: 118 patients were identiﬁed, 61 patients were anaemic on
admission and 83 on discharge, of whom 46 had Hb<10g/dL. Seven (8%) of
the anaemic patients had Fe++ prescribed at discharge. 32 patients received
adjuvant chemotherapy, of these 24 (75%) were anaemic at discharge of
whom 16 (67%) remained anaemic at the start of chemotherapy. The mean
haemoglobin rise between discharge and commencing chemotherapy was
2.1g/dL (SD 0.57) with Fe++ versus 1.6g/dL (SD 1.33) without. Three pa-
tients, all with untreated anaemia required blood transfusion during
chemotherapy.
Conclusions: A majority of patients are anaemic following resectional
surgery for CRC. Treatment at discharge was inadequate at the study
centre. Fe++ may improve restoration of normal haemoglobin prior to
adjuvant chemotherapy with the potential to reduce transfusion
requirement.0387: ASIT-DUKES' CLUB/ACPGBI PRIZE WINNER: CT VIRTUAL COLO-
NOSCOPY (CTVC) AND THE USE OF IV HYOSCINE BUTYLBROMIDE
A.B. Scrimshire, L.J. Steinberg. NHS, North West, UK.
Aims: To assess the effect of IV Hyoscine butylbromide (Buscopan) on
luminal distension for CT virtual colonoscopy (CTVC).
Methods:Over 4months patients were randomly selected and given 20mg
of Buscopan intravenously before undergoing CTVC. These scans were
compared to a set of randomly selected control scans where Buscopan had
not been administered.
Using the same grading system as Taylor et al, a GI radiology consultant
graded all of the images. The colon was divided into 6 segments (Caecum,
Ascending, Transverse, Descending, Sigmoid, Rectum) and each was
graded from 0 (collapsed colon) to 3 (excellent distension, folds <2mm) in
supine and prone positions.
Results: There were 46 patients in total (23 per group). The Buscopan
group showed improved distension in all segments of colon. There was a
50% increase in the number of 3’s scored in the ascending and descending
colon images, 30% for transverse and 20% for rectum and sigmoid. Caecal
imaging had a high rate of 3 scores in both groups. Overall 86% of Buscopan
images scored 3 compared to 54% of non-Buscopan.
Conclusions: The use of IV Buscopan improves colonic distension for CTVC
providing better imaging. This may help avoid repeat investigations.
